Budesonide/Formoterol Added to Tiotropium Improves the Management of COPD Patients.

被引：0
|
作者：
Welte, T.
Miravitlles, M.
Peterson, S. [1 ]
Polanowski, T. [1 ]
Kessler, R.
机构：
[1] AZ, Lund, Sweden
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A6192
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Efficacy of budesonide/formoterol and tiotropium combination for the treatment of Chinese patients with chronic obstructive pulmonary disease
    Feng, Jun-fei
    Ding, Guo-rong
    Xie, Yan-zhong
    Zhao, Dejun
    Wang, Xuehui
    MEDICINE, 2018, 97 (22)
  • [42] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives (vol 29, pg 403, 2011)
    Mittmann, Nicole
    PHARMACOECONOMICS, 2011, 29 (05) : 414 - 414
  • [43] Efficacy and tolerability of budesonide/formoterol (B/F) added to tiotropium (T) vs T alone in East-Asia patients (pts) with severe/very severe chronic obstructive pulmonary disease (COPD)
    Lee, Sang Do
    Xie, Can-mao
    Yunus, Faisal
    Itoh, Yohji
    Su, Rong
    EUROPEAN RESPIRATORY JOURNAL, 2014, 44
  • [44] Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
    Calverley, Peter M.
    Eriksson, Goran
    Jenkins, Christine R.
    Anzueto, Antonio R.
    Make, Barry J.
    Persson, Anders
    Fageras, Malin
    Postma, Dirkje S.
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2017, 12 : 13 - 25
  • [45] Effects of add-on treatment with budesonide/formoterol combination in eosinophilic COPD patients
    Akamatsu, Taisuke
    Shirai, Toshihiro
    Tanaka, Yuko
    Watanabe, Hirofumi
    Endo, Yoshinari
    Shimoda, Yukiko
    Suzuki, Takahito
    Noguchi, Rie
    Saigusa, Mika
    Yamamoto, Akito
    Shishido, Yuichiro
    Akita, Takefumi
    Morita, Satoru
    Asada, Kazuhiro
    EUROPEAN RESPIRATORY JOURNAL, 2017, 50
  • [46] New indication budesonide/formoterol for the maintenance treatment of COPD
    不详
    FORMULARY, 2009, 44 (04) : 101 - 101
  • [47] Early Efficacy Of Budesonide/formoterol In Patients With Moderate, Severe, And Very Severe COPD
    Similowski, T.
    Eriksson, G.
    Postma, D.
    Jenkins, C. R.
    Anzueto, A.
    Make, B. J.
    Fageras, M.
    Persson, A.
    Calverley, P. M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [48] Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
    Kalhan, Ravi
    Slade, David
    Ray, Riju
    Moretz, Chad
    Germain, Guillaume
    Laliberte, Francois
    Shen, Qin
    Duh, Mei Sheng
    MacKnight, Sean Dale
    Hahn, Beth
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2021, 16 : 1149 - 1161
  • [49] REAL-LIFE PERSISTENCE OF BUDESONIDE/FORMOTEROL SPIROMAX FOR THE MANAGEMENT OF ASTHMA AND COPD IN THE UK
    Benhaddi, H.
    Van der Tol, M.
    Price, D.
    Batsiou, M.
    Ariely, R.
    VALUE IN HEALTH, 2016, 19 (07) : A549 - A549
  • [50] Safety and efficacy of concomitant treatment with nebulized formoterol and tiotropium in COPD
    Tashkin, Donald P.
    Littner, Michael R.
    Andrews, Charles P.
    Rinehart, Mike
    Denis-Mize, Kimberly
    CHEST, 2007, 132 (04) : 531S - 532S
12345